Showing results (511-520 of 559) with videos related to

Sort By:
Pageof 56
Cell Reports|October 13, 2021
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasmsKevin C Yang, Steve E Kalloger, John J Aird, et al.
Blood|May 12, 2016
Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphomaSarit E Assouline, Torsten Holm Nielsen, Stephen Yu, et al.
Blood|March 8, 2021
Characterization of DLBCL with a PMBL gene expression signatureGerben Duns, Elena Viganò, Daisuke Ennishi, et al.
Blood|May 8, 2014
A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesisTobias Berg, Silvia Thoene, Damian Yap, et al.
Blood|October 27, 2022
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma populationWaleed Alduaij, Brett Collinge, Susana Ben-Neriah, et al.
Blood Advances|October 24, 2018
High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphologyLauren C Chong, Susana Ben-Neriah, Graham W Slack, et al.
Blood Advances|April 15, 2026
LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphomaLaura K Hilton, Sierra Gillis, Faraneh Yahyaei-Moayyed, et al.
Blood Advances|October 9, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphomaChiara Pighi, Taek-Chin Cheong, Mara Compagno, et al.
Cancer Discovery|February 2, 2019
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune RecognitionDaisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, et al.
Blood|June 2, 2011
Comprehensive analysis of mammalian miRNA* species and their role in myeloid cellsFlorian Kuchenbauer, Sarah M Mah, Michael Heuser, et al.
Pageof 56